Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis
✍ Scribed by İlhan Biçer; Kenan Aksu; Zuhal Parildar; Tijen Tanyalçin; Eker Doğanavşargil; FatmaZ. Kutay
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 183 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Increased activity of urinary N‐acetyl‐β‐D‐glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as the most serious complication of SLE and the st
s disease is characterized by an increased production of glucocorticoids by the adrenal glands secondary to excessive pituitary secretion of adrenocorticotropic hormone (ACTH). Glucocorticoids are known to exert antiinflammatory effects in rheumatoid arthritis (RA). We describe herein a patient with
## Abstract A patient population admitted to the hospital for either SLE or RA was surveyed for the subsequent development of neoplasms. The frequency of neoplasm in SLE patients appeared to be exaggerated, whereas the frequency of subsequent neoplasm in rheumatoid patients was unexpectedly low. A